Investor Guide To Four Pharmaceutical ETFs

The total assets as of Aug 2, 2013 were $513.7 million representing 32 holdings. The fund’s expense ratio is 0.35% and dividend yield is 1.45%. The trading volume is roughly 23,000 shares per day.

iShares U.S. Pharmaceuticals (IHE)

IHE, launched in May 2006, tracks the Dow Jones U.S. Select Pharmaceuticals Index. The fund mainly consists of pharma companies (99.75%). Short term securities and other/unidentified investments account for 0.19% and 0.07% of the fund, respectively.

The top 3 holdings of this fund are large-cap pharma companies – Johnson & Johnson (10.53%), Pfizer (8.73%) and Merck (7.81%). The total assets of the fund as of Aug 2, 2013 were $492.4 million representing 41 holdings.

The fund’s expense ratio is 0.46% with the dividend yield being 1.56%. The trading volume is roughly 35,000 shares per day.

Market Vectors Pharmaceutical (PPH)

PPH was launched in Dec 2011 and tracks the Market Vectors U.S. Listed Pharmaceutical 25 Index. 99.7% of the fund consists of health care stocks with the balance being represented by others. The top 3 holdings of this fund are large-cap pharma companies – Johnson & Johnson (11.09%), Pfizer (9.14%) and Novartis (7.74%).

The total assets as of Aug 2, 2013 were $239.6 million representing 26 holdings. While the expense ratio is 0.35%, dividend yield is 4.15%. The trading volume is roughly 25,000 shares per day.

This article is brought to you courtesy of Eric Dutram.

Pages: 1 2

Leave a Reply

Your email address will not be published. Required fields are marked *